Cargando…

Limb salvage of an infant with infantile fibrosarcoma using TRK inhibitor larotrectinib

Infantile fibrosarcoma (IFS) is an extremely rare locally aggressive soft tissue tumour of childhood. Primary therapy involves complete surgical resection with or without chemotherapy. However complete surgical resection might not be feasible in all cases and so requires other modalities for further...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sahni, Shubham, Rastogi, Sameer, Yadav, Richa, Barwad, Adarsh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cancer Intelligence 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393313/ https://www.ncbi.nlm.nih.gov/pubmed/37533946 http://dx.doi.org/10.3332/ecancer.2023.1575

Ejemplares similares

Larotrectinib as an Effective Therapy in Congenital Infantile Fibrosarcoma: Report of Two Cases
por: Lapeña, Lucas Moratilla, et al.
Publicado: (2022)

Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion
por: Bielack, S S, et al.
Publicado: (2019)

Larotrectinib treatment for infantile fibrosarcoma in newborns: a case report and literature review
por: Wang, Dandan, et al.
Publicado: (2023)

Metastatic sclerosing epithelioid fibrosarcoma in an adult male from a tertiary care centre in India: a case report
por: Santhosh, Akhil, et al.
Publicado: (2022)

Larotrectinib Demonstrates CNS Efficacy in TRK Fusion-Positive Solid Tumors
por: Rosen, Ezra Y., et al.
Publicado: (2019)

Near-complete response to low-dose ceritinib in recurrent infantile inflammatory myofibroblastic tumour
por: Mittal, Abhenil, et al.
Publicado: (2021)

Recurrent infantile inflammatory myofibroblastic tumor of mesentery––Case report and review of imaging findings
por: Gupta, Aarushi, et al.
Publicado: (2020)

Larotrectinib and Entrectinib: TRK Inhibitors for the Treatment of Pediatric and Adult Patients With NTRK Gene Fusion
por: Dunn, Danielle B.
Publicado: (2020)

Efficacy and safety of larotrectinib in patients with TRK fusion-positive thyroid carcinoma
por: Waguespack, Steven G, et al.
Publicado: (2022)

Near-complete response to low-dose ceritinib in recurrent infantile inflammatory myofibroblastic tumour
por: Mittal, Abhenil, et al.
Publicado: (2021)

Cervical congenital infantile fibrosarcoma: a case report
por: Gupta, Alisha, et al.
Publicado: (2019)

The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomas
por: DuBois, Steven G., et al.
Publicado: (2018)

Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib
por: Yang, James C. H., et al.
Publicado: (2022)

Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors
por: Doz, François, et al.
Publicado: (2021)

Case report: Complete and durable response to larotrectinib (TRK inhibitor) in an infant diagnosed with angiosarcoma harbouring a KHDRBS1-NTRK3 fusion gene
por: Cervi, Catherine, et al.
Publicado: (2023)

Infantile Fibrosarcoma of Tongue: A Rare Tumor
por: Wahid, Fazal I, et al.
Publicado: (2016)

Regression of ETV6-NTRK3 Infantile Glioblastoma After First-Line Treatment With Larotrectinib
por: Alharbi, Musa, et al.
Publicado: (2020)

Indirect Treatment Comparison of Larotrectinib versus Entrectinib in Treating Patients with TRK Gene Fusion Cancers
por: Garcia-Foncillas, Jesus, et al.
Publicado: (2022)

Infantile Fibrosarcoma in a Child: a Case Report
por: Hashemi, A, et al.
Publicado: (2013)

Unusual localization and aggressive progression of large infantile fibrosarcoma
por: Atalay, İsmail Burak, et al.
Publicado: (2019)

Long lasting response with trabectedin monotherapy in relapsed metastatic mesenchymal chondrosarcoma
por: Tansir, Ghazal, et al.
Publicado: (2020)

Recurrent Aggressive Fibromatosis Coexisting With Papillary Carcinoma Thyroid – Case Report
por: BG, Bharath, et al.
Publicado: (2023)

Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade glioma
por: Ziegler, David S., et al.
Publicado: (2018)

Larotrectinib in Mismatch-Repair-Deficient TRK Fusion-Positive Metastatic Colon Cancer After Progression on Immunotherapy
por: Kasi, Pashtoon M, et al.
Publicado: (2022)

A Case Report of an Invasive Infantile Fibrosarcoma of the Forearm
por: Kite, Amy C., et al.
Publicado: (2016)

Early clinical and metabolic response to tazemetostat in advanced relapsed INI1 negative epithelioid sarcoma
por: Tansir, Ghazal, et al.
Publicado: (2021)

Challenges in the management of metastatic gastrointestinal stromal tumor in a patient with neurofibromatosis type 1: a case report
por: Bharath, B. G., et al.
Publicado: (2022)

Congenital Infantile Fibrosarcoma Causing Intestinal Perforation in a Newborn
por: Kaiser, Margarita, et al.
Publicado: (2017)

Infantile Fibrosarcoma of the Bone: A Case Report and Literature Review
por: Tfayli, Yehia, et al.
Publicado: (2023)

Economic Evaluation of a Tumour-Agnostic Therapy: Dutch Economic Value of Larotrectinib in TRK Fusion-Positive Cancers
por: Michels, Renée E., et al.
Publicado: (2022)

A case report of Kaposiform haemangioendothelioma; response with propranolol and steroids
por: Verma, Saurav, et al.
Publicado: (2020)

Larotrectinib for solid tumours
Publicado: (2022)

Congenital infantile fibrosarcoma: Association with bleeding diathesis
por: Salman, Mayssaa, et al.
Publicado: (2013)

Good and sustained response to pembrolizumab and pazopanib in advanced undifferentiated pleomorphic sarcoma: a case report
por: Arora, Shalabh, et al.
Publicado: (2020)

Discovery of a rare GKAP1-NTRK2 fusion in a pediatric low-grade glioma, leading to targeted treatment with TRK-inhibitor larotrectinib
por: Deland, Lily, et al.
Publicado: (2021)

Larotrectinib Before Initial Radioactive Iodine Therapy in Pediatric TRK Fusion–Positive Papillary Thyroid Carcinoma: Time to Reconsider the Treatment Paradigm for Distantly Metastatic Disease?
por: Waguespack, Steven G., et al.
Publicado: (2022)

Successful Treatment of Infantile Fibrosarcoma Spinal Metastasis by Chemotherapy and Stereotactic Hypofractionated Radiotherapy
por: Lo, Cheng-Hsiang, et al.
Publicado: (2013)

Genomic Evolution and Personalized Therapy of an Infantile Fibrosarcoma Harboring an NTRK Oncogenic Fusion
por: Thorwarth, Anne, et al.
Publicado: (2022)

Congenital infantile fibrosarcoma: a rare tumor dermatologists should know about()
por: Pereira, Luciana Baptista, et al.
Publicado: (2022)

The Potential Long-Term Comparative Effectiveness of Larotrectinib and Entrectinib for Second-Line Treatment of TRK Fusion-Positive Metastatic Lung Cancer
por: Roth, Joshua A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8havetv1fbi220sedaqs2dlmbg